Chat with us, powered by LiveChat
Toggle Mobile Navigation

Attendee’s Takeaways: 5th Clinical Trials Phase I & Phase IIA Summit

Applied Clinical Trials recently shared an attendee’s takeaways from ExL Events 5th Clinical Trials Phase I & Phase IIA Summit, which took place this past Autumn.

In this article, Moe Alsumidaie, MBA, MSF (Chief Data Scientist at Annex Clinical, and Editorial Advisory Board member/contributor to Applied Clinical Trials) discusses the following three subjects and how ExL’s conference explored them:

Adaptive design in protocol writing

Designing safer early phase studies

Monitoring oversight in early phase trials

For a more complete look at these topics and to learn more about our Clinical Trials Phase I & Phase IIA Summit, read the full article here!

The mission of the Clinical Trials Phase I & Phase IIA Summit is to provide attendees with the strategies and insight necessary to ensure their early stage clinical trials are executed on time and within budget while exploring how to leverage innovative approaches to managing clinical trials for all therapeutic areas.

For the Conference Documentation from ExL Events’ 5th Clinical Trials Phase I & Phase IIA Summit, click here!

posted in ExL Events News

live chat software